IN2014DN08417A - - Google Patents
Info
- Publication number
- IN2014DN08417A IN2014DN08417A IN8417DEN2014A IN2014DN08417A IN 2014DN08417 A IN2014DN08417 A IN 2014DN08417A IN 8417DEN2014 A IN8417DEN2014 A IN 8417DEN2014A IN 2014DN08417 A IN2014DN08417 A IN 2014DN08417A
- Authority
- IN
- India
- Prior art keywords
- formulations
- insulin
- rapid acting
- absorption
- mixing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261624844P | 2012-04-16 | 2012-04-16 | |
| US201261704066P | 2012-09-21 | 2012-09-21 | |
| US13/826,806 US9381247B2 (en) | 2012-04-16 | 2013-03-14 | Magnesium compositions for modulating the pharmacokinetics and pharmacodynamics of insulin and insulin analogs, and injection site pain |
| PCT/US2013/036742 WO2013158618A1 (en) | 2012-04-16 | 2013-04-16 | Magnesium compositions for modulating the pharmacokinetics and pharmacodynamics of insulin and insulin analogs, and injection site pain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN08417A true IN2014DN08417A (xx) | 2015-05-08 |
Family
ID=48326401
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN8417DEN2014 IN2014DN08417A (xx) | 2012-04-16 | 2013-04-16 |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US9381247B2 (xx) |
| EP (2) | EP2838506B1 (xx) |
| JP (2) | JP6422855B2 (xx) |
| KR (1) | KR101966484B1 (xx) |
| CN (1) | CN104394847A (xx) |
| AU (1) | AU2013249495B2 (xx) |
| CA (1) | CA2869883A1 (xx) |
| CY (1) | CY1123825T1 (xx) |
| DK (1) | DK2838506T3 (xx) |
| ES (1) | ES2854874T3 (xx) |
| HK (2) | HK1203371A1 (xx) |
| HR (1) | HRP20210417T1 (xx) |
| HU (1) | HUE053303T2 (xx) |
| IL (1) | IL234987A0 (xx) |
| IN (1) | IN2014DN08417A (xx) |
| LT (1) | LT2838506T (xx) |
| MX (1) | MX2014012245A (xx) |
| PL (1) | PL2838506T3 (xx) |
| PT (1) | PT2838506T (xx) |
| RS (1) | RS61533B1 (xx) |
| RU (1) | RU2014145846A (xx) |
| SG (1) | SG11201406491PA (xx) |
| SI (1) | SI2838506T1 (xx) |
| WO (1) | WO2013158618A1 (xx) |
| ZA (1) | ZA201407410B (xx) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2919804T3 (pl) | 2012-11-13 | 2018-07-31 | Adocia | Szybko działająca formulacja insuliny zawierająca podstawiony związek anionowy |
| WO2015106269A2 (en) * | 2014-01-13 | 2015-07-16 | Thermalin Diabetes, Llc | Rapid action insulin formulations and pharmaceutical delivery systems |
| WO2015120457A1 (en) * | 2014-02-10 | 2015-08-13 | Biodel Inc. | Stabilized ultra-rapid-acting insulin formulations |
| JO3624B1 (ar) * | 2014-05-08 | 2020-08-27 | Lilly Co Eli | تركيبات إنسولين سريعة المفعول |
| EP3659651A3 (en) | 2014-07-10 | 2020-10-14 | Companion Medical, Inc. | Medicine administering system including injection pen and companion device |
| AR102869A1 (es) * | 2014-12-16 | 2017-03-29 | Lilly Co Eli | Composiciones de insulina de rápida acción |
| JP2018505874A (ja) * | 2015-01-20 | 2018-03-01 | ケース ウェスタン リザーブ ユニバーシティＣａｓｅ Ｗｅｓｔｅｒｎ Ｒｅｓｅｒｖｅ Ｕｎｉｖｅｒｓｉｔｙ | 選択的シグナリング特性及びより低い分裂促進性を有するインスリンアナログ |
| JO3749B1 (ar) * | 2015-08-27 | 2021-01-31 | Lilly Co Eli | تركيبات إنسولين سريعة المفعول |
| US10864327B2 (en) | 2016-01-29 | 2020-12-15 | Companion Medical, Inc. | Automatic medication delivery tracking |
| GB201607918D0 (en) | 2016-05-06 | 2016-06-22 | Arecor Ltd | Novel formulations |
| GB201707189D0 (en) * | 2017-05-05 | 2017-06-21 | Arecor Ltd | Novel formulations |
| JP6920471B2 (ja) | 2017-06-01 | 2021-08-18 | イーライ リリー アンド カンパニー | 迅速に作用するインスリン組成物 |
| EP3635591A4 (en) | 2017-06-09 | 2021-03-24 | Companion Medical, Inc. | SMART DRUG DELIVERY SYSTEMS AND PROCESSES |
| US11568975B2 (en) | 2017-10-12 | 2023-01-31 | Medtronic Minimed, Inc. | Intelligent medication delivery systems and methods for dose recommendation and management |
| US11464459B2 (en) | 2017-12-12 | 2022-10-11 | Bigfoot Biomedical, Inc. | User interface for diabetes management systems including flash glucose monitor |
| CA3084613A1 (en) | 2017-12-12 | 2019-06-20 | Bigfoot Biomedical, Inc. | Therapy assist information and/or tracking device and related methods and systems |
| US11077243B2 (en) | 2017-12-12 | 2021-08-03 | Bigfoot Biomedical, Inc. | Devices, systems, and methods for estimating active medication from injections |
| US11116899B2 (en) | 2017-12-12 | 2021-09-14 | Bigfoot Biomedical, Inc. | User interface for diabetes management systems and devices |
| US10987464B2 (en) | 2017-12-12 | 2021-04-27 | Bigfoot Biomedical, Inc. | Pen cap for insulin injection pens and associated methods and systems |
| US11083852B2 (en) | 2017-12-12 | 2021-08-10 | Bigfoot Biomedical, Inc. | Insulin injection assistance systems, methods, and devices |
| US11664107B2 (en) | 2018-05-08 | 2023-05-30 | Medtronic Minimed, Inc. | Intelligent medication delivery systems and methods using a prescription-regulated software application |
| US10898653B2 (en) | 2018-05-08 | 2021-01-26 | Companion Medical, Inc. | Intelligent medication delivery systems and methods for dose setting and dispensing monitoring |
| USD893020S1 (en) | 2018-05-11 | 2020-08-11 | Companion Medical, Inc. | Injection pen |
| US11587663B2 (en) | 2018-06-20 | 2023-02-21 | Medtronic Minimed, Inc. | Intelligent medication delivery systems and methods for medicine dose calculation and reporting |
| USD892819S1 (en) | 2018-06-20 | 2020-08-11 | Companion Medical, Inc. | Display screen with graphical user interface |
| FR3083984A1 (fr) | 2018-07-23 | 2020-01-24 | Adocia | Dispositif pour injecter une solution d'insuline(s) |
| FR3083985A1 (fr) | 2018-07-23 | 2020-01-24 | Adocia | Dispositif pour injecter une solution d'insuline(s) |
| WO2019243627A1 (fr) | 2018-06-23 | 2019-12-26 | Adocia | Dispositif pour injecter une solution d'insuline(s) |
| US11948671B2 (en) | 2019-04-11 | 2024-04-02 | Medtronic Minimed, Inc. | Intelligent accessories for medicine dispensing device |
| US11701473B2 (en) | 2021-06-23 | 2023-07-18 | Medtronic Minimed, Inc. | Reusable injection pens |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4196196A (en) | 1978-06-19 | 1980-04-01 | Tiholiz Ivan C | Divalen/monovalent bipolar cation therapy for enhancement of tissue perfusion and reperfusion in disease states |
| PH23446A (en) * | 1986-10-20 | 1989-08-07 | Novo Industri As | Peptide preparations |
| DK503386D0 (da) * | 1986-10-20 | 1986-10-20 | Novo Industri As | Peptidpraeparater |
| EP2221361A3 (en) | 1996-08-30 | 2011-02-09 | Life Technologies Corporation | Method for producing a polypeptide in vitro in mammalian cells in a protein-free and serum-free culture medium |
| JP2002500196A (ja) * | 1998-01-09 | 2002-01-08 | ノヴォ ノルディスク アクティーゼルスカブ | 安定化させたインスリン組成物 |
| US20080085298A1 (en) | 2004-03-12 | 2008-04-10 | Biodel, Inc. | Rapid Mucosal Gel or Film Insulin Compositions |
| AU2005222613B2 (en) | 2004-03-12 | 2009-12-17 | Biodel, Inc. | Rapid acting drug delivery compositions |
| US20080090753A1 (en) | 2004-03-12 | 2008-04-17 | Biodel, Inc. | Rapid Acting Injectable Insulin Compositions |
| US20080096800A1 (en) | 2004-03-12 | 2008-04-24 | Biodel, Inc. | Rapid mucosal gel or film insulin compositions |
| WO2008100636A2 (en) | 2007-02-17 | 2008-08-21 | President And Fellows Of Harvard College | Compositions and method for tissue preservation |
| TWI394580B (zh) * | 2008-04-28 | 2013-05-01 | Halozyme Inc | 超快起作用胰島素組成物 |
| US9060927B2 (en) * | 2009-03-03 | 2015-06-23 | Biodel Inc. | Insulin formulations for rapid uptake |
| FR2943538B1 (fr) * | 2009-03-27 | 2011-05-20 | Adocia | Formulation a action rapide d'insuline recombinante humaine |
| EP2590667A4 (en) | 2010-07-07 | 2013-11-27 | Biodel Inc | COMPOSITIONS AND METHODS FOR THE MODULATION OF PHARMACOKINETICS AND PHARMACODYNAMIC INSULIN |
-
2013
- 2013-03-14 US US13/826,806 patent/US9381247B2/en active Active
- 2013-04-16 DK DK13721441.7T patent/DK2838506T3/da active
- 2013-04-16 SI SI201331836T patent/SI2838506T1/sl unknown
- 2013-04-16 MX MX2014012245A patent/MX2014012245A/es unknown
- 2013-04-16 LT LTEP13721441.7T patent/LT2838506T/lt unknown
- 2013-04-16 SG SG11201406491PA patent/SG11201406491PA/en unknown
- 2013-04-16 RS RS20210209A patent/RS61533B1/sr unknown
- 2013-04-16 HU HUE13721441A patent/HUE053303T2/hu unknown
- 2013-04-16 PL PL13721441T patent/PL2838506T3/pl unknown
- 2013-04-16 AU AU2013249495A patent/AU2013249495B2/en active Active
- 2013-04-16 CA CA2869883A patent/CA2869883A1/en not_active Abandoned
- 2013-04-16 PT PT137214417T patent/PT2838506T/pt unknown
- 2013-04-16 EP EP13721441.7A patent/EP2838506B1/en active Active
- 2013-04-16 EP EP20215156.9A patent/EP3827813A1/en not_active Withdrawn
- 2013-04-16 RU RU2014145846A patent/RU2014145846A/ru not_active Application Discontinuation
- 2013-04-16 JP JP2015505989A patent/JP6422855B2/ja active Active
- 2013-04-16 KR KR1020147032221A patent/KR101966484B1/ko active IP Right Grant
- 2013-04-16 WO PCT/US2013/036742 patent/WO2013158618A1/en active Application Filing
- 2013-04-16 ES ES13721441T patent/ES2854874T3/es active Active
- 2013-04-16 CN CN201380029323.7A patent/CN104394847A/zh active Pending
- 2013-04-16 IN IN8417DEN2014 patent/IN2014DN08417A/en unknown
-
2014
- 2014-10-05 IL IL234987A patent/IL234987A0/en unknown
- 2014-10-13 ZA ZA2014/07410A patent/ZA201407410B/en unknown
-
2015
- 2015-04-22 HK HK15103911.3A patent/HK1203371A1/xx unknown
- 2015-08-25 HK HK15108257.4A patent/HK1207577A1/xx unknown
-
2018
- 2018-10-16 JP JP2018194834A patent/JP2019023223A/ja active Pending
-
2021
- 2021-02-10 CY CY20211100113T patent/CY1123825T1/el unknown
- 2021-03-12 HR HRP20210417TT patent/HRP20210417T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| LT2838506T (lt) | 2021-03-25 |
| WO2013158618A1 (en) | 2013-10-24 |
| US20140113856A1 (en) | 2014-04-24 |
| PL2838506T3 (pl) | 2021-06-28 |
| ZA201407410B (en) | 2015-06-24 |
| US9381247B2 (en) | 2016-07-05 |
| EP2838506B1 (en) | 2021-01-06 |
| CN104394847A (zh) | 2015-03-04 |
| MX2014012245A (es) | 2015-06-05 |
| RS61533B1 (sr) | 2021-04-29 |
| EP2838506A1 (en) | 2015-02-25 |
| CY1123825T1 (el) | 2022-05-27 |
| RU2014145846A (ru) | 2016-06-10 |
| HUE053303T2 (hu) | 2021-06-28 |
| ES2854874T3 (es) | 2021-09-23 |
| CA2869883A1 (en) | 2013-10-24 |
| KR101966484B1 (ko) | 2019-04-05 |
| JP2019023223A (ja) | 2019-02-14 |
| EP3827813A1 (en) | 2021-06-02 |
| JP6422855B2 (ja) | 2018-11-14 |
| SG11201406491PA (en) | 2014-11-27 |
| AU2013249495B2 (en) | 2016-05-12 |
| PT2838506T (pt) | 2021-02-23 |
| HK1207577A1 (en) | 2016-02-05 |
| KR20140146209A (ko) | 2014-12-24 |
| DK2838506T3 (da) | 2021-01-18 |
| SI2838506T1 (sl) | 2021-02-26 |
| HK1203371A1 (en) | 2015-10-30 |
| JP2015512952A (ja) | 2015-04-30 |
| HRP20210417T1 (hr) | 2021-04-30 |
| IL234987A0 (en) | 2014-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014DN08417A (xx) | ||
| MX2010003776A (es) | Composiciones de insulina inyectables de accion rapida. | |
| ZA202102906B (en) | Liquid protein formulations containing viscosity-lowering agents | |
| MX2011009174A (es) | Formulaciones de insulina para captacion rapida. | |
| AU2016204371A1 (en) | Lyophilised and aqueous anti-CD40 antibody formulations | |
| CO7101246A2 (es) | Compuesto de carbamato y preparación y uso de los mismos | |
| UA115139C2 (uk) | Спосіб доставки фармацевтичної композиції, яка містить омепразол й ацетилсаліцилову кислоту, пацієнту | |
| HRP20220692T1 (hr) | Brzodjelujući pripravci inzulina | |
| EA201690102A1 (ru) | Фармацевтическая композиция, содержащая диметилфумарат, для введения в низкой суточной дозе | |
| PH12016500296A1 (en) | Sodium channel modulators for the treatment of pain and diabetes | |
| NZ627274A (en) | Anesthetic compounds and related methods of use | |
| MX2009013663A (es) | Formulacion solubilizada de docetaxel sin tween 80. | |
| IN2012DE00337A (xx) | ||
| PH12015501373A1 (en) | Injectable depot formulation comprising optically active tolvaptan and process of producing the same | |
| MY191043A (en) | Stabilized pharmaceutical composition containing pemetrexed or pharmaceutically acceptable salt thereof | |
| IN2014MN02156A (xx) | ||
| EA201592297A1 (ru) | Композиции агомелатина, содержащие агомелатин в форме сокристаллов | |
| MX2010002348A (es) | Formulacion liquida de g-csf. | |
| MX359106B (es) | Composicion farmaceutica inyectable de dexketoprofeno y tramadol. | |
| EA201500128A1 (ru) | Педиатрические жидкие композиции для перорального введения, содержащие непадутант | |
| BR112014018426A8 (pt) | Composição e dispositivo para administração transdérmica, e, método para administrar uma progestina | |
| EA201391512A1 (ru) | Твердая фармацевтическая композиция | |
| ES2422563A1 (es) | Composición farmacéutica inyectable de ibuprofeno y arginina, su procedimiento de preparación, forma de dosificación unitaria y utilización de la misma | |
| PH12017501005A1 (en) | Injectable formulations of paracetamol | |
| RU2016145411A (ru) | Комбинация брекспипразола и налмефена, и ее применение для лечения синдрома химической зависимости |